SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001144204-19-023725
Filing Date
2019-05-06
Accepted
2019-05-06 06:06:59
Documents
15
Period of Report
2019-05-05

Document Format Files

Seq Description Document Type Size
1 FORM 6-K tv520710_6k.htm 6-K 40388
2 GRAPHIC image_001.jpg GRAPHIC 4267
3 GRAPHIC image_002.jpg GRAPHIC 46125
4 GRAPHIC image_003.jpg GRAPHIC 18257
5 GRAPHIC image_004.jpg GRAPHIC 91491
6 GRAPHIC image_005.jpg GRAPHIC 66230
7 GRAPHIC image_006.jpg GRAPHIC 54916
8 GRAPHIC image_007.jpg GRAPHIC 61349
9 GRAPHIC image_008.jpg GRAPHIC 46859
10 GRAPHIC image_009.jpg GRAPHIC 61139
11 GRAPHIC image_010.jpg GRAPHIC 69671
12 GRAPHIC image_011.jpg GRAPHIC 61905
13 GRAPHIC image_012.jpg GRAPHIC 73405
14 GRAPHIC image_013.jpg GRAPHIC 33615
15 GRAPHIC image_014.jpg GRAPHIC 61416
  Complete submission text file 0001144204-19-023725.txt   1074708
Mailing Address LEVEL 3, 460 BOURKE STREET MELBOURNE C3 VIC 3000
Business Address LEVEL 3, 460 BOURKE STREET MELBOURNE C3 VIC 3000 61 3 9349 4906
ALTERITY THERAPEUTICS LTD (Filer) CIK: 0001131343 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 000-49843 | Film No.: 19797985
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1